Filter
1297
Text search:
Vaccine
production
Featured
Recommendations
145
New Publications
320
Language
Document type
No document type
556
Studies & Reports
300
Guidelines
181
Strategic & Response Plan
94
Manuals
74
Fact sheets
43
Training Material
16
Situation Updates
15
Resource Platforms
6
Brochures
4
Infographics
4
Online Courses
2
App
1
Videos
1
Countries / Regions
Global
98
Nigeria
43
India
37
Kenya
37
Sierra Leone
32
Ethiopia
27
Latin America and the Carribbean
27
Africa
27
Liberia
25
Tanzania
24
South Africa
24
Uganda
20
Ghana
19
Nepal
18
Zambia
17
Congo, Democratic Republic of
16
Western and Central Europe
15
Bangladesh
14
Malawi
13
Philippines
12
Syria
12
Rwanda
12
Zimbabwe
11
Pakistan
11
Lesotho
11
West and Central Africa
11
Ukraine
10
Myanmar / Burma
10
Haiti
9
Mozambique
9
Namibia
9
South–East Asia Region
9
South Sudan
8
East and Southern Africa
8
Middle East and North Africa
8
Senegal
7
Sudan
7
Guinea
6
Brazil
6
Afghanistan
5
Germany
5
Cambodia
5
Indonesia
5
Botswana
5
Eswatini/ Swaziland
4
Eastern Europe
4
Mali
3
USA
3
Iraq
3
Jordan
3
Lebanon
3
Thailand
3
Benin
3
Madagascar
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Laos
3
United Kingdom
3
Burkina Faso
2
Saudi Arabia
2
Togo
2
Turkey
2
Egypt
2
Papua New Guinea
2
Libya
2
Sri Lanka
2
Yemen
2
Paraguay
2
Timor Leste/ East Timor
2
Vietnam
2
Cameroon
1
Somalia
1
Chad
1
China
1
Central African Republic
1
Argentina
1
Peru
1
North Macedonia
1
Burundi
1
Colombia
1
Bolivia
1
Chile
1
Other region
1
Palestine
1
Djibouti
1
Tajikistan
1
Russia
1
Qatar
1
Moldova
1
Iran
1
Georgia
1
Turkmenistan
1
France
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
481
Clinical Guidelines
132
Public Health
67
Key Resources
57
Women & Child Health
53
Pharmacy & Technologies
21
Capacity Building
6
Toolboxes
COVID-19
221
AMR
62
TB
60
NTDs
58
Rapid Response
46
Health Financing Toolbox
46
HIV
45
Ebola & Marburg
44
Planetary Health
43
Global Health Education
30
Conflict
29
2.0 Rapid Response
27
Pharmacy
25
Cholera
23
Polio
20
Malaria
18
Natural Hazards
17
Caregiver
14
Refugee
12
Mental Health
11
NCDs
10
Disability
7
Specific Hazards
6
Zika
4
South Sudan
1
Accessed Febr. 6, 2020
Le gouvernement du Bénin a engagé le processus de mise en oeuvre du RAMU dans le but d’améliorer l’accessibilité fi nancière des populations à un paquet de base de soins de santé de qualité. Commencées en 2008, la réflexion, la préparation et la mise en oeuvre du RAMU au Bénin ont fa
...
Les maladies infectieuses sont en constante mutation. De nouvelles maladies apparaissent, d’autres qui sont bien connues se propagent ou refont surface, et quelques rares fois, une maladie est éradiquée. Les maladies infectieuses telles que le VIH, la tuberculose et le choléra sont des causes c
...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Mozambique registered its first COVID-19 case on 22 March 2020 and since then numbers have steadily grown over the following three months with cases now reported in all provinces. In response, a level 3 State of emergency was enacted on 1 April 2020 and has been extended until 29 July 2020, with mea
...
The report provides the much-needed evidence to design interventions for children in Kenya and as such we urge partners to use this report as a document for planning for children.
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
Only 8,730 asylum applications were registered in the EU+ in April, the lowest since at least 2008, and a massive 87% decrease from pre-COVID-19 levels in January and February.
The European Asylum Support Office (EASO) has released a special report which shows that the COVID-19 related travel restr
...
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance.
T
...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi
...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs
...
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline
...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
One of the most important ways we feel we can help to reduce the burden of cancer in Africa is to work with African cancer advocacy organisations to help educate and advocate about cancer in their countries. To this end in 2010 we designed with our partners, 13 posters for use in Africa
giving heal
...
